Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for PCVX

Stock NameVaxcyte Inc
TickerPCVX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92243G1085
LEI254900M7NMHTGASX8D95

Show aggregate PCVX holdings

News associated with PCVX

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $106.25 Average Price Target from Analysts
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-09-16 02:32:42
Swiss National Bank Has $8.21 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Swiss National Bank reduced its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.8% in the 1st quarter, HoldingsChannel reports. The fund owned 217,300 shares of the company’s stock after selling 1,700 shares during the period. Swiss National Bank’s holdings in Vaxcyte were worth $8,205,000 at the end of the most recent quarter. Several […] - 2025-08-17 05:55:01
Natixis Advisors LLC Decreases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Natixis Advisors LLC lowered its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 5.7% during the first quarter, Holdings Channel reports. The institutional investor owned 14,649 shares of the company’s stock after selling 888 shares during the period. Natixis Advisors LLC’s holdings in Vaxcyte were worth $553,000 at the end of the […] - 2025-08-12 04:38:46
Analysts Forecast 12% Upside For JHML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:29
KLP Kapitalforvaltning AS Buys 500 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
KLP Kapitalforvaltning AS increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 2.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after purchasing an additional 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Vaxcyte […] - 2025-07-29 06:16:55
Universal Beteiligungs und Servicegesellschaft mbH Buys 3,634 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 3.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 107,317 shares of the company’s stock after buying an additional 3,634 shares during the quarter. Universal […] - 2025-07-29 05:22:57
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […] - 2025-07-28 02:30:52
New York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
New York State Common Retirement Fund increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 190.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 137,440 shares of the company’s stock after purchasing an additional 90,145 shares during the quarter. New York […] - 2025-07-22 07:09:01
Principal Financial Group Inc. Has $17.73 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Principal Financial Group Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 52.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 469,561 shares of the company’s stock after acquiring an additional 160,622 shares during the period. […] - 2025-07-11 05:21:08
Calamos Advisors LLC Has $257,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Calamos Advisors LLC decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 32.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,794 shares of the company’s stock after selling 3,201 shares during the period. Calamos Advisors LLC’s holdings in Vaxcyte were worth […] - 2025-07-08 05:46:54
Vaxcyte, Inc. (NASDAQ:PCVX) Holdings Lowered by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC trimmed its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 43.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,990 shares of the company’s stock after selling 257,533 shares during the […] - 2025-07-04 05:06:38
Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Price Target at $136.50
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among […] - 2025-07-03 02:42:45
Analyzing Vaxcyte (NASDAQ:PCVX) & Genenta Science (NASDAQ:GNTA)
Genenta Science (NASDAQ:GNTA – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility & Risk Genenta Science has a beta of […] - 2025-06-13 02:32:52
The Math Shows ESML Can Go To $48
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of “Buy” from Brokerages
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts […] - 2025-06-05 02:32:50
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM)
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility Vaxcyte has a beta of 1.27, […] - 2025-05-30 02:28:51
Millennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company’s stock after selling 21,857 shares during the quarter. Millennium Management LLC owned approximately […] - 2025-05-21 05:46:50
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 115.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 293,706 shares of the company’s stock after buying an additional 157,277 shares during the period. Dimensional Fund Advisors LP’s holdings in Vaxcyte were worth $24,043,000 at the end of the […] - 2025-05-07 05:22:50
Mariner LLC Has $487,000 Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Mariner LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 27.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,947 shares of the company’s stock after buying an additional 1,290 shares during the period. Mariner LLC’s holdings in Vaxcyte were worth $487,000 as of its most recent filing with the Securities […] - 2025-05-02 05:10:52
Renaissance Technologies LLC Purchases Shares of 54,077 Vaxcyte, Inc. (NASDAQ:PCVX)
Renaissance Technologies LLC acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,077 shares of the company’s stock, valued at approximately $4,427,000. A number of other hedge funds and other institutional investors […] - 2025-04-22 05:03:18
ILCB's Holdings Imply 27% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:46:47
Norges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX)
Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company’s stock, valued at approximately $90,069,000. Norges Bank owned about 0.88% of Vaxcyte at the end of the most […] - 2025-04-03 05:36:54
Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […] - 2025-04-03 04:24:52
Needham & Company LLC Has Lowered Expectations for Vaxcyte (NASDAQ:PCVX) Stock Price
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $140.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 167.14% from the […] - 2025-04-03 04:24:52
Monday's ETF Movers: FBT, XBI
In trading on Monday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Corcept Therapeutics, up about 83.2% and shares of Amgen, up about 2% on the - 2025-03-31 13:11:30
Proficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX)
Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,609 shares of the company’s stock, valued at approximately $2,915,000. Several other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors […] - 2025-03-19 05:44:45
PNC Financial Services Group Inc. Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX)
PNC Financial Services Group Inc. increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,076 shares of the company’s stock after acquiring an additional 1,397 shares during the period. PNC Financial Services Group Inc.’s holdings […] - 2025-03-18 05:38:57
Victory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company’s stock after purchasing an additional 48,516 shares during the quarter. Victory Capital Management Inc. owned […] - 2025-03-11 06:16:48
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $127.71
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […] - 2025-02-28 04:06:48
After-Hours Earnings Report for February 25, 2025 : INTU, WDAY, ALC, CPNG, AXON, EXR, KEYS, FSLR, CART, CAVA, PCVX, PR
The following companies are expected to report earnings after hours on 02/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Intuit Inc. (INTU)is reporting for the quarter ending January 31, 2025. The computer software company's consensus earnings - 2025-02-25 17:00:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) PCVX holdings

DateNumber of PCVX Shares HeldBase Market Value of PCVX SharesLocal Market Value of PCVX SharesChange in PCVX Shares HeldChange in PCVX Base ValueCurrent Price per PCVX Share HeldPrevious Price per PCVX Share Held
2025-11-11 (Tuesday)84,123USD 3,841,056PCVX holding increased by 230497USD 3,841,0560USD 230,497 USD 45.66 USD 42.92
2025-11-10 (Monday)84,123PCVX holding increased by 215USD 3,610,559PCVX holding increased by 115791USD 3,610,559215USD 115,791 USD 42.92 USD 41.65
2025-11-07 (Friday)83,908USD 3,494,768PCVX holding decreased by -5035USD 3,494,7680USD -5,035 USD 41.65 USD 41.71
2025-11-06 (Thursday)83,908PCVX holding increased by 215USD 3,499,803PCVX holding increased by 125301USD 3,499,803215USD 125,301 USD 41.71 USD 40.32
2025-11-05 (Wednesday)83,693USD 3,374,502PCVX holding decreased by -86204USD 3,374,5020USD -86,204 USD 40.32 USD 41.35
2025-11-04 (Tuesday)83,693PCVX holding increased by 216USD 3,460,706PCVX holding decreased by -114614USD 3,460,706216USD -114,614 USD 41.35 USD 42.83
2025-11-03 (Monday)83,477USD 3,575,320PCVX holding decreased by -204519USD 3,575,3200USD -204,519 USD 42.83 USD 45.28
2025-10-31 (Friday)83,477USD 3,779,839PCVX holding increased by 44243USD 3,779,8390USD 44,243 USD 45.28 USD 44.75
2025-10-30 (Thursday)83,477PCVX holding increased by 1080USD 3,735,596PCVX holding increased by 149679USD 3,735,5961,080USD 149,679 USD 44.75 USD 43.52
2025-10-29 (Wednesday)82,397PCVX holding increased by 432USD 3,585,917PCVX holding decreased by -67263USD 3,585,917432USD -67,263 USD 43.52 USD 44.57
2025-10-28 (Tuesday)81,965USD 3,653,180USD 3,653,1800USD 0 USD 44.57 USD 44.57
2025-10-27 (Monday)81,965USD 3,653,180PCVX holding increased by 191798USD 3,653,1800USD 191,798 USD 44.57 USD 42.23
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCVX by Blackrock for IE00BYXG2H39

Show aggregate share trades of PCVX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY21543.67041.435 41.659USD 8,957 56.51
2025-11-06BUY21542.03040.160 40.347USD 8,675 56.66
2025-11-04BUY21643.21640.790 41.033USD 8,863 56.82
2025-10-30BUY1,08045.69043.040 43.305USD 46,769 57.02
2025-10-29BUY43243.52045.130 44.969USD 19,427 57.09
2025-10-22SELL-86442.51043.400 43.311USD -37,421 57.46 Profit of 12,225 on sale
2025-10-20BUY43242.90043.300 43.260USD 18,688 57.62
2025-10-17BUY1,07942.39043.910 43.758USD 47,215 57.70
2025-10-15BUY1,72043.94045.130 45.011USD 77,419 57.78
2025-10-03BUY1,49842.66043.120 43.074USD 64,525 57.94
2025-10-02BUY21440.13040.240 40.229USD 8,609 58.04
2025-09-30BUY42836.02036.575 36.520USD 15,630 58.28
2025-09-26BUY42833.98034.110 34.097USD 14,594 58.55
2025-09-25BUY42832.14032.900 32.824USD 14,049 58.70
2025-09-24SELL-3,21032.82033.930 33.819USD -108,559 58.85 Profit of 80,356 on sale
2025-09-18BUY22332.59032.840 32.815USD 7,318 59.00
2025-09-17BUY67230.88533.160 32.932USD 22,131 59.17
2025-09-05SELL-22333.02033.600 33.542USD -7,480 59.65 Profit of 5,821 on sale
2025-08-20SELL-89231.26031.920 31.854USD -28,414 60.16 Profit of 25,247 on sale
2025-07-30BUY89234.82036.515 36.345USD 32,420 61.20
2025-07-17SELL-44637.37037.920 37.865USD -16,888 62.70 Profit of 11,077 on sale
2025-07-16BUY76236.57036.790 36.768USD 28,017 62.88
2025-07-11SELL-1,76835.93036.140 36.119USD -63,858 63.43 Profit of 48,279 on sale
2025-07-07BUY66332.00033.170 33.053USD 21,914 64.24
2025-07-02BUY12,15533.27034.415 34.301USD 416,923 64.68
2025-06-20BUY1,98032.87033.710 33.626USD 66,579 64.91
2025-06-11BUY42835.44037.450 37.249USD 15,943 66.52
2025-06-10BUY42837.20037.650 37.605USD 16,095 66.75
2025-06-04SELL-21433.84035.420 35.262USD -7,546 67.72 Profit of 6,945 on sale
2025-04-23BUY21433.16034.400 34.276USD 7,335 78.41
2025-04-10SELL-1,71228.04030.480 30.236USD -51,764 83.27 Profit of 90,786 on sale
2025-04-08SELL-21430.20033.750 33.395USD -7,147 84.48 Profit of 10,932 on sale
2025-04-07SELL-21432.51034.110 33.950USD -7,265 85.08 Profit of 10,942 on sale
2025-04-04SELL-1,07031.60033.250 33.085USD -35,401 85.71 Profit of 56,311 on sale
2025-04-01BUY1,24232.23037.920 37.351USD 46,390 86.98
2025-03-21BUY4,39974.66076.610 76.415USD 336,150 88.85
2025-03-14SELL-3,13674.37075.040 74.973USD -235,115 89.83 Profit of 46,583 on sale
2025-03-07SELL-39271.18075.080 74.690USD -29,278 91.24 Profit of 6,486 on sale
2025-03-04SELL-19670.24072.365 72.152USD -14,142 92.11 Profit of 3,911 on sale
2025-02-25BUY39279.35082.770 82.428USD 32,312 93.54
2025-02-19SELL-19683.36083.710 83.675USD -16,400 94.41 Profit of 2,104 on sale
2025-02-13BUY58883.84086.445 86.184USD 50,676 95.27
2025-02-12BUY19685.42086.680 86.554USD 16,965 95.48
2025-02-11BUY78485.13085.503 85.466USD 67,005 95.69
2025-01-02BUY29283.30084.800 84.650USD 24,718 98.68
2024-12-30SELL-17981.99082.210 82.188USD -14,712 99.19 Profit of 3,043 on sale
2024-11-18SELL-2,88086.49087.320 87.237USD -251,243 108.16 Profit of 60,246 on sale
2024-11-08SELL-192106.670107.305 107.242USD -20,590 108.89 Profit of 316 on sale
2024-10-30BUY268106.110107.670 107.514USD 28,814 111.98
2024-10-21SELL-191115.450115.970 115.918USD -22,140 0.00 Loss of -22,140 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCVX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19204,24681702,29129.1%
2025-09-18247,3181471,182,12220.9%
2025-09-17478,61801,628,29629.4%
2025-09-16258,6320784,30133.0%
2025-09-15193,594318494,38039.2%
2025-09-12262,3070527,65949.7%
2025-09-11181,6190473,83938.3%
2025-09-10278,9386810,10834.4%
2025-09-09197,2761,000484,76440.7%
2025-09-08356,154300666,46453.4%
2025-09-05251,6680581,15043.3%
2025-09-04288,8274,175579,05449.9%
2025-09-03282,3050622,62645.3%
2025-09-02220,3200734,35730.0%
2025-08-29107,9760267,83540.3%
2025-08-28260,5540594,66643.8%
2025-08-27179,7460724,10324.8%
2025-08-26114,1000664,62817.2%
2025-08-25196,8460900,65721.9%
2025-08-22120,8500342,73535.3%
2025-08-21153,745120483,24331.8%
2025-08-20118,3800353,36033.5%
2025-08-19113,5500325,27734.9%
2025-08-18156,8690446,08335.2%
2025-08-15144,4531,997521,83527.7%
2025-08-14214,7060564,08838.1%
2025-08-13219,025671,278,22117.1%
2025-08-12247,22889705,27935.1%
2025-08-11233,662136622,09637.6%
2025-08-08117,17110,8411,145,85810.2%
2025-08-07318,95520,8871,174,51827.2%
2025-08-06125,4830261,57148.0%
2025-08-05114,223106238,07548.0%
2025-08-04100,2050238,74842.0%
2025-08-01140,1902,064321,07743.7%
2025-07-31128,7450378,86734.0%
2025-07-30138,6300351,93439.4%
2025-07-29181,456445398,37845.5%
2025-07-28128,91069541,00623.8%
2025-07-25143,535100357,21940.2%
2025-07-24112,578199342,45032.9%
2025-07-23116,822100187,70062.2%
2025-07-22162,681225214,66775.8%
2025-07-21255,787100321,41979.6%
2025-07-18262,89466397,87866.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.